Enrico Moiso

665 total citations
13 papers, 263 citations indexed

About

Enrico Moiso is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Enrico Moiso has authored 13 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Enrico Moiso's work include Advanced Breast Cancer Therapies (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Enrico Moiso is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Enrico Moiso collaborates with scholars based in United States, Italy and Belarus. Enrico Moiso's co-authors include Paolo Provero, Chiara Riganti, Joanna Kopecka, Menachem Rubinstein, Elisa Panada, Ilaria Buondonno, Iris C. Salaroglio, Emanuele Monteleone, Davide Schiavone and Lidia Avalle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Immunity.

In The Last Decade

Enrico Moiso

11 papers receiving 260 citations

Peers

Enrico Moiso
Chunxu Yang China
Cynthia I. Chude United States
Gilles Rademaker Belgium
Alicia M. Blessing United States
Mohammad Farooq South Korea
Shufeng Ji China
Christopher M. Dower United States
Bing Yu China
Kun Cai China
Jennifer S. Carew United States
Chunxu Yang China
Enrico Moiso
Citations per year, relative to Enrico Moiso Enrico Moiso (= 1×) peers Chunxu Yang

Countries citing papers authored by Enrico Moiso

Since Specialization
Citations

This map shows the geographic impact of Enrico Moiso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrico Moiso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrico Moiso more than expected).

Fields of papers citing papers by Enrico Moiso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrico Moiso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrico Moiso. The network helps show where Enrico Moiso may publish in the future.

Co-authorship network of co-authors of Enrico Moiso

This figure shows the co-authorship network connecting the top 25 collaborators of Enrico Moiso. A scholar is included among the top collaborators of Enrico Moiso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrico Moiso. Enrico Moiso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mahat, Dig Bijay, Heena Kumra, Kim B. Nguyen, et al.. (2025). Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer. Immunity. 58(7). 1688–1705.e9. 4 indexed citations
2.
Moiso, Enrico, Emanuela Ferraro, Luc Cabel, et al.. (2025). Abstract GS3-09: Multimodal integration of real world clinical and genomic data for the prediction of CDK4/6 inhibitors outcomes in patients with HR+/HER2- metastatic breast cancer. Clinical Cancer Research. 31(12_Supplement). GS3–9. 1 indexed citations
3.
Tsai, Chun‐Ming, Luc Cabel, Enrico Moiso, et al.. (2024). 418P Concordance of PI3K-AKT pathway alterations between tumor and ctDNA in metastatic breast cancer. Annals of Oncology. 35. S395–S396.
4.
Moiso, Enrico, Emanuela Ferraro, Luc Cabel, et al.. (2024). Predicting CDK4/6 inhibitors outcomes in pts with HR+/HER2- metastatic breast cancer: A machine learning approach.. Journal of Clinical Oncology. 42(16_suppl). 1074–1074. 1 indexed citations
5.
Ferraro, Emanuela, Enrico Moiso, Anton Safonov, et al.. (2024). Overall survival analysis of first line CDK4/6 inhibitors in a large real-world cohort of patients with hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer.. Journal of Clinical Oncology. 42(16_suppl). e13095–e13095.
6.
Moiso, Enrico, Alexander Farahani, Hetal D. Marble, et al.. (2022). Developmental Deconvolution for Classification of Cancer Origin. Cancer Discovery. 12(11). 2566–2585. 12 indexed citations
7.
Audrito, Valentina, Enrico Moiso, Filippo Ugolini, et al.. (2022). Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties. Journal of Translational Medicine. 20(1). 118–118. 5 indexed citations
8.
Moiso, Enrico & Paolo Provero. (2022). Cancer Metabolic Subtypes and Their Association with Molecular and Clinical Features. Cancers. 14(9). 2145–2145. 4 indexed citations
9.
Dalin, Simona, et al.. (2021). Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel. Proceedings of the National Academy of Sciences. 118(34). 13 indexed citations
10.
Audrito, Valentina, Enrico Moiso, Nicoletta Vitale, et al.. (2020). NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. Cancers. 12(12). 3855–3855. 19 indexed citations
11.
Monteleone, Emanuele, Davide Schiavone, Lidia Avalle, et al.. (2019). SP1 and STAT3 Functionally Synergize to Induce the RhoU Small GTPase and a Subclass of Non-canonical WNT Responsive Genes Correlating with Poor Prognosis in Breast Cancer. Cancers. 11(1). 101–101. 26 indexed citations
12.
Salaroglio, Iris C., Elisa Panada, Enrico Moiso, et al.. (2017). PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy. Molecular Cancer. 16(1). 91–91. 157 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunxu Yang Breakdown of academic impact, for papers by Cynthia I. Chude Breakdown of academic impact, for papers by Gilles Rademaker Breakdown of academic impact, for papers by Alicia M. Blessing Breakdown of academic impact, for papers by Mohammad Farooq Breakdown of academic impact, for papers by Shufeng Ji Breakdown of academic impact, for papers by Christopher M. Dower Breakdown of academic impact, for papers by Bing Yu Breakdown of academic impact, for papers by Kun Cai Breakdown of academic impact, for papers by Jennifer S. Carew
Rankless by CCL
2026